News Daily News Rivaroxaban Again Linked to More Bleeding vs Other DOACs Caitlin E. Cox October 11, 2021
News Conference News ESC 2021 Amulet IDE: LAA Occluder Performs Well Against Watchman Todd Neale August 30, 2021
News Conference News ESC 2021 ENVISAGE-TAVI AF: Edoxaban Disappoints in TAVI Setting Todd Neale August 28, 2021
News Conference News TVT 2021 New-Generation Watchman FLX Maintains Good Results Through 2 Years Todd Neale July 28, 2021
News Daily News Traditional Cath Lab Practices Scrutinized, Some Debunked, in AHA Statement Todd Neale July 05, 2021
News Conference News ACC 2021 Low 1-Year Stroke Risk After Commercial Watchman Use Todd Neale May 15, 2021
News Conference News ACC 2021 ATLANTIS: Apixaban Has No Benefit Over Standard of Care Post-TAVI Yael L. Maxwell May 15, 2021
News Conference News ACC 2021 Occluding the LAA During Surgery Lowers Stroke Risk: LAAOS III Todd Neale May 15, 2021
News Features Roughly 80% of ESC Guideline Writers Have Financial COIs Michael O'Riordan April 01, 2021
News Conference News CRT 2021 DOAC Use Increasing in Patients With Bioprosthetic Heart Valves Todd Neale March 08, 2021